Central Institutional Review Board (CIRB)
The CIRB provides an innovative approach to human subject protection through a "facilitated review" process that can streamline local IRB reviews of adult and pediatric national multi-center cancer treatment trials.
Currently over 336 institutions in over 45 states are participating in the Initiative.
Reviews Cooperative Group Clinical Trials
The CIRB Initiative has been designed to: